Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merus Labs International Inc (NASDAQ:MSLI)

0.76
Delayed Data
As of 9:30am ET
 -0.016 / -2.06%
Today’s Change
0.70
Today|||52-Week Range
1.76
-12.64%
Year-to-Date
No recent news for Merus Labs International Inc.

Today’s Trading

Previous close0.78
Today’s open0.76
Day’s range0.76 - 0.76
Volume27,000
Average volume (3 months)27,486
Market cap$90.8M
Dividend yield--
Data as of 9:30am ET, 04/26/2017

Growth & Valuation

Earnings growth (last year)-3,133.33%
Earnings growth (this year)+50.64%
Earnings growth (next 5 years)+1.14%
Revenue growth (last year)+72.51%
P/E ratio--
Price/Sales1.62
Price/Book0.60

Competitors

 Today’s
change
Today’s
% change
AGRXAgile Therapeutics I...+0.07+2.19%
AGLEAeglea Bio Therapeut...0.000.00%
ALIMAlimera Sciences Inc0.000.00%
BDSIBioDelivery Sciences...+0.05+2.94%
Data as of 10:06am ET, 04/26/2017

Financials

Next reporting dateMay 17, 2017
EPS forecast (this quarter)-$0.01
Annual revenue (last year)$68.7M
Annual profit (last year)-$7.1M
Net profit margin-10.39%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
Barry Fishman
Chief Financial Officer &
Investor Contact
Michael Bumby
Corporate headquarters
Toronto, Ontario

Forecasts


Search for Jobs